Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency

Pembrolizumab is an immune checkpoint inhibitor that targets the programmed cell death protein 1 (PD-1) antigen and induces an immune response against tumor tissues. It has been successful in inducing remission in patients with severe metastatic disease, often refractory to other chemotherapeutic ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, Ramy M., Selamet, Umut, Bui, Patrick, Sun, Shih-Fan, Shenouda, Olivia, Nobakht, Niloofar, Barsoum, Marina, Arman, Farid, Rastogi, Anjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120420/
https://www.ncbi.nlm.nih.gov/pubmed/30197906
http://dx.doi.org/10.1159/000491631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120420/
https://www.ncbi.nlm.nih.gov/pubmed/30197906
http://dx.doi.org/10.1159/000491631

Ejemplares similares